Specialized regulatory T cells control venous blood clot resolution through SPARC
Author(s) -
Fatemeh Zare Shahneh,
Alexandra Grill,
Matthias Klein,
Felix Frauhammer,
Tobias Bopp,
Katrin Schäfer,
Verena Raker,
Christian Becker
Publication year - 2020
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2020005407
Subject(s) - clot formation , resorption , matricellular protein , monocyte , population , immunology , venous blood , chemistry , medicine , microbiology and biotechnology , platelet , biology , extracellular matrix , biochemistry , environmental health
The cells and mechanisms involved in blood clot resorption are only partially known. We show that regulatory T cells (Tregs) accumulate in venous blood clots and regulate thrombolysis by controlling the recruitment, differentiation and matrix metalloproteinase (MMP) activity of monocytes. We describe a clot Treg population that forms the matricellular acid– and cysteine-rich protein SPARC (secreted protein acidic and rich in cysteine) and show that SPARC enhances monocyte MMP activity and that SPARC+ Tregs are crucial for blood clot resorption. By comparing different treatment times, we define a therapeutic window of Treg expansion that accelerates clot resorption.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom